Order Drugs Now

TEL: 1 866 893 0369
FAX: 1 800 878 7930


Medical News

Subscribe to Newsletter

To get info on the latest products, specials and pharmacy news, please enter your e-mail address:


 

August 7th, 2009
Baxter Completes CELVAPAN A/H1N1 Pandemic Vaccine

Baxter International has recently announced that they have finished the production of their first commerical batches of CELVAPAN A/H1N1 pandemic vaccine.

August 7th, 2009
FDA Demands TNF Blockers to Include Cancer Warnings

The US FDA requires TNF blockers to include firm detailed warnings in the prescribing information.

August 7th, 2009
Leading Cause of Child Poisonings: Medication

A recent Government report states that the foremost source of poisonings among American children can be located in the household medicine cabinet.

August 7th, 2009
FDA Warns: Clarcon Skin Products Present Health Threats

The US FDA cautions consumers of the harmful effects Clarcon skin products are having on the skin. They urge consumers to cease all usage of Clarcon Biological Chemistry Laboratory skin sanitizer or protectants, because of hazardous bacteria.

August 7th, 2009
Insmed Maintains Limited IPLEX Supply for Existing Patients

Biopharmaceutical company Insmed Inc. has publicized that effective immediately, they will halt new patient distribution of Iplex. They feel it is in the existing patients best interest to maintain supplies at this time for their treatment only. As a result, at this time, Insmed will not instigate further clinical trials of Iplex.

August 7th, 2009
FDA Makes Provisions to Botox/Botox Cosmetics, Dysport and Myobloc

The US FDA has announced and advised healthcare providers of modifications to the well-known drug names for Botox / Botox Cosmetics, Dysport and Myobloc. These modifications are in the hopes to provide healthcare professionals advice on how to avoid medication inaccuracy, and reinforce individual potency. The modifications are also to provide additional information to patients, family members and caregivers.

August 7th, 2009
US FDA Supports Once-Daily Diabetes Treatment Onglyza

Recently, the US FDA has approved a once-daily tablet to treat adult Type 2 Diabetes. Along with diet and exercise, Onglyza will assist to manage high blood sugar levels.

August 7th, 2009
US FDA Supports Antipsychotic Once-Monthly Invega Sustenna

The US FDA has recently approved Invega Sustenna extended-release injectable suspension for acute and maintenance therapy of adult schizophrenia. Invega Sustenna is the first US approved once a month injectable, long-acting, atypical antipsychotic.

August 7th, 2009
Gene Responsible For Age Related Cataracts

Scientists have discovered a gene that appears to be associated with the formation of age related cataracts - a condition that leads to blindness

August 7th, 2009
Americans: Increasingly Accepting of Psych Drugs

A new study reveals that Americans are increasingly accepting and possess a positive attitude on psychiatric medications.

SEARCH

Search for Medication or Types of Conditions

SHOPPING CART

cart

Items in cart: 0
Total: $0.00

view my cart check out credit cards

Find out how much you can save now!

try
download order form

ALL PRESCRIPTION DRUGS FILLED BY:

Medicine Shoppe Pharmacy
148 #9 31205 Old Yale Road
Abbotsford BC, Canada

Ph: 1-866-893-0369
Fax: 1-800-878-7930

Licence J30
Manager: S. Maan

 

TEL: 1 (866) 893-0369
FAX: 1 (800) 878-7930